Concepedia

Carolyn J. Loveridge

CJ

13

Publications

932

Citations

12

H-Index

2005

Active since

Affiliations

Cancer Research UK Scotland Institute(Current)

Western General Hospital

Edinburgh Cancer Research

University of Glasgow

University of Edinburgh

Carolyn J. Loveridge is an author at Cancer Research UK Scotland Institute specializing in cell death, cell signaling, and medicine.

ORCID

Top concepts

Publications per year

2005–2019

13

Publications

13

The DAZL family proteins are PABP‐binding proteins that regulate translation in germ cells

B. Collier, Barbara Gorgoni, Carolyn J. Loveridge et al. · The EMBO Journal · 2005 · 229 citations · Full text

FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells

Francesca Tonelli, Keng Gat Lim, Carolyn J. Loveridge et al. · Cellular Signalling · 2010 · 179 citations · Full text

<i>Sleeping Beauty</i>screen reveals<i>Pparg</i>activation in metastatic prostate cancer

Imran Ahmad, Ernest Mui, Laura C.A. Galbraith et al. · Proceedings of the National Academy of Sciences · 2016 · 119 citations · Full text

The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells

Carolyn J. Loveridge, Francesca Tonelli, Tamara Leclercq et al. · Journal of Biological Chemistry · 2010 · 117 citations · Full text

, , +16

Nucleolar Targeting of RelA(p65) Is Regulated by COMMD1-Dependent Ubiquitination

Hazel C. Thoms, Carolyn J. Loveridge, James Simpson et al. · Cancer Research · 2010 · 69 citations

Rows per page

1–5 of 13